Literature DB >> 23591271

High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects.

William Busse, Sheldon Spector, Karin Rosén, Yan Wang, Oral Alpan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591271     DOI: 10.1016/j.jaci.2013.02.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  37 in total

Review 1.  Biologic therapies targeting eosinophils: current status and future prospects.

Authors:  Fanny Legrand; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

Review 2.  Biologics in asthma--the next step toward personalized treatment.

Authors:  Jared Darveaux; William W Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

Review 3.  Predictive Biomarkers for Asthma Therapy.

Authors:  Sarah K Medrek; Amit D Parulekar; Nicola A Hanania
Journal:  Curr Allergy Asthma Rep       Date:  2017-09-19       Impact factor: 4.806

Review 4.  Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.

Authors:  Melanie C Dispenza; Bruce S Bochner
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

Review 5.  Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.

Authors:  Jared M Odegard; Gerald T Nepom; Erik Wambre
Journal:  Clin Immunol       Date:  2015-06-27       Impact factor: 3.969

Review 6.  Evolving Concepts of Asthma.

Authors:  Marc Gauthier; Anuradha Ray; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

Review 7.  The use of biologics in personalized asthma care.

Authors:  David Watchorn; Fernando Holguin
Journal:  Expert Rev Clin Immunol       Date:  2021-11-23       Impact factor: 4.473

Review 8.  Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Authors:  David Aguirre-Valencia; Iván Posso-Osorio; Juan-Carlos Bravo; Fabio Bonilla-Abadía; Gabriel J Tobón; Carlos A Cañas
Journal:  Clin Rheumatol       Date:  2017-07-31       Impact factor: 2.980

9.  Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent Asthma.

Authors:  William J Sheehan; Rebecca Z Krouse; Agustin Calatroni; Peter J Gergen; James E Gern; Michelle A Gill; Rebecca S Gruchalla; Gurjit K Khurana Hershey; Meyer Kattan; Carolyn M Kercsmar; Carin I Lamm; Frederic F Little; Melanie M Makhija; Daniel A Searing; Edward Zoratti; William W Busse; Stephen J Teach
Journal:  J Allergy Clin Immunol Pract       Date:  2020-05-04

10.  The role of eosinophils in immunotherapy.

Authors: 
Journal:  Curr Opin Allergy Clin Immunol       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.